7143 Search Results


94
Tocris vx765
Inflammasome inhibitors delay VPRH-mediated cell death. Approximately 3.5*10 4 wild-type BMDMs were seeded into 96-well plates in triplicate, and were primed using LPS (100 ng/ml) for 3 h prior to infection with V. proteolyticus mutants at MOI 50. Where indicated, inflammasome inhibitors – <t>Vx765</t> (25 μM), MCC950 (20 μM), or NSA (20 μM), with the addition of propidium iodide (PI) (1 μg/ml), were added to the cells 30 min prior to bacterial infection. DMSO was added as the solvent control. (A) PI uptake was assessed using real-time microscopy (IncucyteZOOM) and then graphed as the percentage of PI-positive cells normalized to the number of cells in wells. Data are presented as the mean ± SD; n = 3. (B) Summary of normalized AUC for three independent biological experiments shown in panel A. (C-E) Cell lysates and supernatants from experiments described in A were collected 6 h post-infection. (C, D) IL-1β (C) and TNFα (D) secretion were measured using commercial ELISA kits. (E, F) Inflammasome components, caspase-1 (Casp1), GSDMD, and IL-1β cleavage were detected in BMDM lysates (E) and supernatants (F) using immunoblots (the numbers on the right of each blot indicate the blot number). The data in A, E, and F are representative of 3 independent experiments. Statistical comparisons in B, C and D between the different bacterial mutants and inflammasome inhibitors were carried using RM two-way ANOVA, followed by Tukey's multiple comparison test; the results are presented as the mean (bars) ± SD of 3 independent experiments; significant differences are denoted only for comparisons between inhibitors in each infected strain; * P < 0.05, ** P < 0.01.
Vx765, supplied by Tocris, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/vx765/product/Tocris
Average 94 stars, based on 1 article reviews
vx765 - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

99
Cell Signaling Technology Inc akt1
Inflammasome inhibitors delay VPRH-mediated cell death. Approximately 3.5*10 4 wild-type BMDMs were seeded into 96-well plates in triplicate, and were primed using LPS (100 ng/ml) for 3 h prior to infection with V. proteolyticus mutants at MOI 50. Where indicated, inflammasome inhibitors – <t>Vx765</t> (25 μM), MCC950 (20 μM), or NSA (20 μM), with the addition of propidium iodide (PI) (1 μg/ml), were added to the cells 30 min prior to bacterial infection. DMSO was added as the solvent control. (A) PI uptake was assessed using real-time microscopy (IncucyteZOOM) and then graphed as the percentage of PI-positive cells normalized to the number of cells in wells. Data are presented as the mean ± SD; n = 3. (B) Summary of normalized AUC for three independent biological experiments shown in panel A. (C-E) Cell lysates and supernatants from experiments described in A were collected 6 h post-infection. (C, D) IL-1β (C) and TNFα (D) secretion were measured using commercial ELISA kits. (E, F) Inflammasome components, caspase-1 (Casp1), GSDMD, and IL-1β cleavage were detected in BMDM lysates (E) and supernatants (F) using immunoblots (the numbers on the right of each blot indicate the blot number). The data in A, E, and F are representative of 3 independent experiments. Statistical comparisons in B, C and D between the different bacterial mutants and inflammasome inhibitors were carried using RM two-way ANOVA, followed by Tukey's multiple comparison test; the results are presented as the mean (bars) ± SD of 3 independent experiments; significant differences are denoted only for comparisons between inhibitors in each infected strain; * P < 0.05, ** P < 0.01.
Akt1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/akt1/product/Cell Signaling Technology Inc
Average 99 stars, based on 1 article reviews
akt1 - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

90
Omron Healthcare automated oscillometric method hem-7143-e
Inflammasome inhibitors delay VPRH-mediated cell death. Approximately 3.5*10 4 wild-type BMDMs were seeded into 96-well plates in triplicate, and were primed using LPS (100 ng/ml) for 3 h prior to infection with V. proteolyticus mutants at MOI 50. Where indicated, inflammasome inhibitors – <t>Vx765</t> (25 μM), MCC950 (20 μM), or NSA (20 μM), with the addition of propidium iodide (PI) (1 μg/ml), were added to the cells 30 min prior to bacterial infection. DMSO was added as the solvent control. (A) PI uptake was assessed using real-time microscopy (IncucyteZOOM) and then graphed as the percentage of PI-positive cells normalized to the number of cells in wells. Data are presented as the mean ± SD; n = 3. (B) Summary of normalized AUC for three independent biological experiments shown in panel A. (C-E) Cell lysates and supernatants from experiments described in A were collected 6 h post-infection. (C, D) IL-1β (C) and TNFα (D) secretion were measured using commercial ELISA kits. (E, F) Inflammasome components, caspase-1 (Casp1), GSDMD, and IL-1β cleavage were detected in BMDM lysates (E) and supernatants (F) using immunoblots (the numbers on the right of each blot indicate the blot number). The data in A, E, and F are representative of 3 independent experiments. Statistical comparisons in B, C and D between the different bacterial mutants and inflammasome inhibitors were carried using RM two-way ANOVA, followed by Tukey's multiple comparison test; the results are presented as the mean (bars) ± SD of 3 independent experiments; significant differences are denoted only for comparisons between inhibitors in each infected strain; * P < 0.05, ** P < 0.01.
Automated Oscillometric Method Hem 7143 E, supplied by Omron Healthcare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/automated oscillometric method hem-7143-e/product/Omron Healthcare
Average 90 stars, based on 1 article reviews
automated oscillometric method hem-7143-e - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Farmitalia Carlo Erba Srl glipizide lot mp605/ 7143
Inflammasome inhibitors delay VPRH-mediated cell death. Approximately 3.5*10 4 wild-type BMDMs were seeded into 96-well plates in triplicate, and were primed using LPS (100 ng/ml) for 3 h prior to infection with V. proteolyticus mutants at MOI 50. Where indicated, inflammasome inhibitors – <t>Vx765</t> (25 μM), MCC950 (20 μM), or NSA (20 μM), with the addition of propidium iodide (PI) (1 μg/ml), were added to the cells 30 min prior to bacterial infection. DMSO was added as the solvent control. (A) PI uptake was assessed using real-time microscopy (IncucyteZOOM) and then graphed as the percentage of PI-positive cells normalized to the number of cells in wells. Data are presented as the mean ± SD; n = 3. (B) Summary of normalized AUC for three independent biological experiments shown in panel A. (C-E) Cell lysates and supernatants from experiments described in A were collected 6 h post-infection. (C, D) IL-1β (C) and TNFα (D) secretion were measured using commercial ELISA kits. (E, F) Inflammasome components, caspase-1 (Casp1), GSDMD, and IL-1β cleavage were detected in BMDM lysates (E) and supernatants (F) using immunoblots (the numbers on the right of each blot indicate the blot number). The data in A, E, and F are representative of 3 independent experiments. Statistical comparisons in B, C and D between the different bacterial mutants and inflammasome inhibitors were carried using RM two-way ANOVA, followed by Tukey's multiple comparison test; the results are presented as the mean (bars) ± SD of 3 independent experiments; significant differences are denoted only for comparisons between inhibitors in each infected strain; * P < 0.05, ** P < 0.01.
Glipizide Lot Mp605/ 7143, supplied by Farmitalia Carlo Erba Srl, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/glipizide lot mp605/ 7143/product/Farmitalia Carlo Erba Srl
Average 90 stars, based on 1 article reviews
glipizide lot mp605/ 7143 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Scanditronix gmbh ionizing chamber scanditronix medical rk no. 7143
Inflammasome inhibitors delay VPRH-mediated cell death. Approximately 3.5*10 4 wild-type BMDMs were seeded into 96-well plates in triplicate, and were primed using LPS (100 ng/ml) for 3 h prior to infection with V. proteolyticus mutants at MOI 50. Where indicated, inflammasome inhibitors – <t>Vx765</t> (25 μM), MCC950 (20 μM), or NSA (20 μM), with the addition of propidium iodide (PI) (1 μg/ml), were added to the cells 30 min prior to bacterial infection. DMSO was added as the solvent control. (A) PI uptake was assessed using real-time microscopy (IncucyteZOOM) and then graphed as the percentage of PI-positive cells normalized to the number of cells in wells. Data are presented as the mean ± SD; n = 3. (B) Summary of normalized AUC for three independent biological experiments shown in panel A. (C-E) Cell lysates and supernatants from experiments described in A were collected 6 h post-infection. (C, D) IL-1β (C) and TNFα (D) secretion were measured using commercial ELISA kits. (E, F) Inflammasome components, caspase-1 (Casp1), GSDMD, and IL-1β cleavage were detected in BMDM lysates (E) and supernatants (F) using immunoblots (the numbers on the right of each blot indicate the blot number). The data in A, E, and F are representative of 3 independent experiments. Statistical comparisons in B, C and D between the different bacterial mutants and inflammasome inhibitors were carried using RM two-way ANOVA, followed by Tukey's multiple comparison test; the results are presented as the mean (bars) ± SD of 3 independent experiments; significant differences are denoted only for comparisons between inhibitors in each infected strain; * P < 0.05, ** P < 0.01.
Ionizing Chamber Scanditronix Medical Rk No. 7143, supplied by Scanditronix gmbh, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ionizing chamber scanditronix medical rk no. 7143/product/Scanditronix gmbh
Average 90 stars, based on 1 article reviews
ionizing chamber scanditronix medical rk no. 7143 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
OGUSSA GmbH technovit 7143
Inflammasome inhibitors delay VPRH-mediated cell death. Approximately 3.5*10 4 wild-type BMDMs were seeded into 96-well plates in triplicate, and were primed using LPS (100 ng/ml) for 3 h prior to infection with V. proteolyticus mutants at MOI 50. Where indicated, inflammasome inhibitors – <t>Vx765</t> (25 μM), MCC950 (20 μM), or NSA (20 μM), with the addition of propidium iodide (PI) (1 μg/ml), were added to the cells 30 min prior to bacterial infection. DMSO was added as the solvent control. (A) PI uptake was assessed using real-time microscopy (IncucyteZOOM) and then graphed as the percentage of PI-positive cells normalized to the number of cells in wells. Data are presented as the mean ± SD; n = 3. (B) Summary of normalized AUC for three independent biological experiments shown in panel A. (C-E) Cell lysates and supernatants from experiments described in A were collected 6 h post-infection. (C, D) IL-1β (C) and TNFα (D) secretion were measured using commercial ELISA kits. (E, F) Inflammasome components, caspase-1 (Casp1), GSDMD, and IL-1β cleavage were detected in BMDM lysates (E) and supernatants (F) using immunoblots (the numbers on the right of each blot indicate the blot number). The data in A, E, and F are representative of 3 independent experiments. Statistical comparisons in B, C and D between the different bacterial mutants and inflammasome inhibitors were carried using RM two-way ANOVA, followed by Tukey's multiple comparison test; the results are presented as the mean (bars) ± SD of 3 independent experiments; significant differences are denoted only for comparisons between inhibitors in each infected strain; * P < 0.05, ** P < 0.01.
Technovit 7143, supplied by OGUSSA GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/technovit 7143/product/OGUSSA GmbH
Average 90 stars, based on 1 article reviews
technovit 7143 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Heraeus Kulzer technovitt 7143
Inflammasome inhibitors delay VPRH-mediated cell death. Approximately 3.5*10 4 wild-type BMDMs were seeded into 96-well plates in triplicate, and were primed using LPS (100 ng/ml) for 3 h prior to infection with V. proteolyticus mutants at MOI 50. Where indicated, inflammasome inhibitors – <t>Vx765</t> (25 μM), MCC950 (20 μM), or NSA (20 μM), with the addition of propidium iodide (PI) (1 μg/ml), were added to the cells 30 min prior to bacterial infection. DMSO was added as the solvent control. (A) PI uptake was assessed using real-time microscopy (IncucyteZOOM) and then graphed as the percentage of PI-positive cells normalized to the number of cells in wells. Data are presented as the mean ± SD; n = 3. (B) Summary of normalized AUC for three independent biological experiments shown in panel A. (C-E) Cell lysates and supernatants from experiments described in A were collected 6 h post-infection. (C, D) IL-1β (C) and TNFα (D) secretion were measured using commercial ELISA kits. (E, F) Inflammasome components, caspase-1 (Casp1), GSDMD, and IL-1β cleavage were detected in BMDM lysates (E) and supernatants (F) using immunoblots (the numbers on the right of each blot indicate the blot number). The data in A, E, and F are representative of 3 independent experiments. Statistical comparisons in B, C and D between the different bacterial mutants and inflammasome inhibitors were carried using RM two-way ANOVA, followed by Tukey's multiple comparison test; the results are presented as the mean (bars) ± SD of 3 independent experiments; significant differences are denoted only for comparisons between inhibitors in each infected strain; * P < 0.05, ** P < 0.01.
Technovitt 7143, supplied by Heraeus Kulzer, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/technovitt 7143/product/Heraeus Kulzer
Average 90 stars, based on 1 article reviews
technovitt 7143 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Verlag GmbH 7138chemistryselect 2019, 4, 7134–7143
Inflammasome inhibitors delay VPRH-mediated cell death. Approximately 3.5*10 4 wild-type BMDMs were seeded into 96-well plates in triplicate, and were primed using LPS (100 ng/ml) for 3 h prior to infection with V. proteolyticus mutants at MOI 50. Where indicated, inflammasome inhibitors – <t>Vx765</t> (25 μM), MCC950 (20 μM), or NSA (20 μM), with the addition of propidium iodide (PI) (1 μg/ml), were added to the cells 30 min prior to bacterial infection. DMSO was added as the solvent control. (A) PI uptake was assessed using real-time microscopy (IncucyteZOOM) and then graphed as the percentage of PI-positive cells normalized to the number of cells in wells. Data are presented as the mean ± SD; n = 3. (B) Summary of normalized AUC for three independent biological experiments shown in panel A. (C-E) Cell lysates and supernatants from experiments described in A were collected 6 h post-infection. (C, D) IL-1β (C) and TNFα (D) secretion were measured using commercial ELISA kits. (E, F) Inflammasome components, caspase-1 (Casp1), GSDMD, and IL-1β cleavage were detected in BMDM lysates (E) and supernatants (F) using immunoblots (the numbers on the right of each blot indicate the blot number). The data in A, E, and F are representative of 3 independent experiments. Statistical comparisons in B, C and D between the different bacterial mutants and inflammasome inhibitors were carried using RM two-way ANOVA, followed by Tukey's multiple comparison test; the results are presented as the mean (bars) ± SD of 3 independent experiments; significant differences are denoted only for comparisons between inhibitors in each infected strain; * P < 0.05, ** P < 0.01.
7138chemistryselect 2019, 4, 7134–7143, supplied by Verlag GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/7138chemistryselect 2019, 4, 7134–7143/product/Verlag GmbH
Average 90 stars, based on 1 article reviews
7138chemistryselect 2019, 4, 7134–7143 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
OGUSSA GmbH ausgusse mit technovit 7143
Inflammasome inhibitors delay VPRH-mediated cell death. Approximately 3.5*10 4 wild-type BMDMs were seeded into 96-well plates in triplicate, and were primed using LPS (100 ng/ml) for 3 h prior to infection with V. proteolyticus mutants at MOI 50. Where indicated, inflammasome inhibitors – <t>Vx765</t> (25 μM), MCC950 (20 μM), or NSA (20 μM), with the addition of propidium iodide (PI) (1 μg/ml), were added to the cells 30 min prior to bacterial infection. DMSO was added as the solvent control. (A) PI uptake was assessed using real-time microscopy (IncucyteZOOM) and then graphed as the percentage of PI-positive cells normalized to the number of cells in wells. Data are presented as the mean ± SD; n = 3. (B) Summary of normalized AUC for three independent biological experiments shown in panel A. (C-E) Cell lysates and supernatants from experiments described in A were collected 6 h post-infection. (C, D) IL-1β (C) and TNFα (D) secretion were measured using commercial ELISA kits. (E, F) Inflammasome components, caspase-1 (Casp1), GSDMD, and IL-1β cleavage were detected in BMDM lysates (E) and supernatants (F) using immunoblots (the numbers on the right of each blot indicate the blot number). The data in A, E, and F are representative of 3 independent experiments. Statistical comparisons in B, C and D between the different bacterial mutants and inflammasome inhibitors were carried using RM two-way ANOVA, followed by Tukey's multiple comparison test; the results are presented as the mean (bars) ± SD of 3 independent experiments; significant differences are denoted only for comparisons between inhibitors in each infected strain; * P < 0.05, ** P < 0.01.
Ausgusse Mit Technovit 7143, supplied by OGUSSA GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ausgusse mit technovit 7143/product/OGUSSA GmbH
Average 90 stars, based on 1 article reviews
ausgusse mit technovit 7143 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Inflammasome inhibitors delay VPRH-mediated cell death. Approximately 3.5*10 4 wild-type BMDMs were seeded into 96-well plates in triplicate, and were primed using LPS (100 ng/ml) for 3 h prior to infection with V. proteolyticus mutants at MOI 50. Where indicated, inflammasome inhibitors – Vx765 (25 μM), MCC950 (20 μM), or NSA (20 μM), with the addition of propidium iodide (PI) (1 μg/ml), were added to the cells 30 min prior to bacterial infection. DMSO was added as the solvent control. (A) PI uptake was assessed using real-time microscopy (IncucyteZOOM) and then graphed as the percentage of PI-positive cells normalized to the number of cells in wells. Data are presented as the mean ± SD; n = 3. (B) Summary of normalized AUC for three independent biological experiments shown in panel A. (C-E) Cell lysates and supernatants from experiments described in A were collected 6 h post-infection. (C, D) IL-1β (C) and TNFα (D) secretion were measured using commercial ELISA kits. (E, F) Inflammasome components, caspase-1 (Casp1), GSDMD, and IL-1β cleavage were detected in BMDM lysates (E) and supernatants (F) using immunoblots (the numbers on the right of each blot indicate the blot number). The data in A, E, and F are representative of 3 independent experiments. Statistical comparisons in B, C and D between the different bacterial mutants and inflammasome inhibitors were carried using RM two-way ANOVA, followed by Tukey's multiple comparison test; the results are presented as the mean (bars) ± SD of 3 independent experiments; significant differences are denoted only for comparisons between inhibitors in each infected strain; * P < 0.05, ** P < 0.01.

Journal: Emerging Microbes & Infections

Article Title: Vibrio pore-forming leukocidin activates pyroptotic cell death via the NLRP3 inflammasome

doi: 10.1080/22221751.2020.1720526

Figure Lengend Snippet: Inflammasome inhibitors delay VPRH-mediated cell death. Approximately 3.5*10 4 wild-type BMDMs were seeded into 96-well plates in triplicate, and were primed using LPS (100 ng/ml) for 3 h prior to infection with V. proteolyticus mutants at MOI 50. Where indicated, inflammasome inhibitors – Vx765 (25 μM), MCC950 (20 μM), or NSA (20 μM), with the addition of propidium iodide (PI) (1 μg/ml), were added to the cells 30 min prior to bacterial infection. DMSO was added as the solvent control. (A) PI uptake was assessed using real-time microscopy (IncucyteZOOM) and then graphed as the percentage of PI-positive cells normalized to the number of cells in wells. Data are presented as the mean ± SD; n = 3. (B) Summary of normalized AUC for three independent biological experiments shown in panel A. (C-E) Cell lysates and supernatants from experiments described in A were collected 6 h post-infection. (C, D) IL-1β (C) and TNFα (D) secretion were measured using commercial ELISA kits. (E, F) Inflammasome components, caspase-1 (Casp1), GSDMD, and IL-1β cleavage were detected in BMDM lysates (E) and supernatants (F) using immunoblots (the numbers on the right of each blot indicate the blot number). The data in A, E, and F are representative of 3 independent experiments. Statistical comparisons in B, C and D between the different bacterial mutants and inflammasome inhibitors were carried using RM two-way ANOVA, followed by Tukey's multiple comparison test; the results are presented as the mean (bars) ± SD of 3 independent experiments; significant differences are denoted only for comparisons between inhibitors in each infected strain; * P < 0.05, ** P < 0.01.

Article Snippet: Necrosulfinamide (NSA) was purchased from Tocris Bioscience; Vx765 and MCC950 were purchased from Invitrogen.

Techniques: Infection, Solvent, Control, Microscopy, Enzyme-linked Immunosorbent Assay, Western Blot, Comparison

Inflammasome inhibitors delay VPRH-mediated cell death in human PBMCs. Approximately 2*10 4 healthy donor PBMCs were seeded into 96-well plates in triplicate for 18 h prior to infection with V. proteolyticus mutants at MOI 50. Where indicated, inflammasome inhibitors – Vx765 (25 μM) or MCC950 (20 μM), with the addition of propidium iodide (PI) (1 μg/ml), were added to the cells 30 min prior to bacterial infection. DMSO was added as the solvent control. In donor 1, only the inhibitor VX765 was applied. (A) PI uptake was assessed using real-time microscopy (IncucyteZOOM) and then graphed as the percentage of PI-positive cells normalized to the number of cells in wells. Data are presented as the mean ± SD; n = 3. (B) Summary of normalized AUC for the three donors shown in panel A. (C) Supernatants from experiments described in A were collected 4 h post-infection, and IL-1β secretion was measured using commercial ELISA kit. Statistical comparisons in B and C between the different bacterial mutants and inflammasome inhibitors were carried using RM two-way ANOVA, followed by Tukey's multiple comparison test; the results are presented as the mean (bars) ± SD of 3 independent experiments; significant differences are denoted only for the comparisons between PBMCs infected with WT V. proteolyticus and the other condition; ** P < 0.01.

Journal: Emerging Microbes & Infections

Article Title: Vibrio pore-forming leukocidin activates pyroptotic cell death via the NLRP3 inflammasome

doi: 10.1080/22221751.2020.1720526

Figure Lengend Snippet: Inflammasome inhibitors delay VPRH-mediated cell death in human PBMCs. Approximately 2*10 4 healthy donor PBMCs were seeded into 96-well plates in triplicate for 18 h prior to infection with V. proteolyticus mutants at MOI 50. Where indicated, inflammasome inhibitors – Vx765 (25 μM) or MCC950 (20 μM), with the addition of propidium iodide (PI) (1 μg/ml), were added to the cells 30 min prior to bacterial infection. DMSO was added as the solvent control. In donor 1, only the inhibitor VX765 was applied. (A) PI uptake was assessed using real-time microscopy (IncucyteZOOM) and then graphed as the percentage of PI-positive cells normalized to the number of cells in wells. Data are presented as the mean ± SD; n = 3. (B) Summary of normalized AUC for the three donors shown in panel A. (C) Supernatants from experiments described in A were collected 4 h post-infection, and IL-1β secretion was measured using commercial ELISA kit. Statistical comparisons in B and C between the different bacterial mutants and inflammasome inhibitors were carried using RM two-way ANOVA, followed by Tukey's multiple comparison test; the results are presented as the mean (bars) ± SD of 3 independent experiments; significant differences are denoted only for the comparisons between PBMCs infected with WT V. proteolyticus and the other condition; ** P < 0.01.

Article Snippet: Necrosulfinamide (NSA) was purchased from Tocris Bioscience; Vx765 and MCC950 were purchased from Invitrogen.

Techniques: Infection, Solvent, Control, Microscopy, Enzyme-linked Immunosorbent Assay, Comparison